Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects
Clinical trial NCT02869347 · COMPLETED
Trial details
- NCT number
- NCT02869347
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.